STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Data were presented from the phase IIa trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of the American Association for the Study of Liver Diseases in Boston, USA.
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Data were presented from the phase IIa trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of the American Association for the Study of Liver Diseases in Boston, USA.
